Filed: 2/2/2024ACC: 0001104659-24-010045
📋 What this filing means
KINNEVIK AB (PUBL) filed this quarterly 13F‑HR report disclosing 1 equity positions with a total reported market value of $102.60M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
1
Positions
$102.60M
Total AUM (reported)
10.41M
Total Shares
Allocation by class
CL A$102.60M100.0%
Portfolio Concentration
Top 3$102.60M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 10.41M
Sole
Full voting authority
10.41M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other1
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings1
Rows:
Recursion Pharmaceuticals, Inc.
DFNDShares10.41M
TypeSH
Market value$102.60M
100.00%
Sole
10.41M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc.DFND | CL A | 10.41M | SH | $102.60M 100.00% | 10.41M | 0.00 | 0.00 |